samedan logo
 
 
 
spacer
home > pmps > summer 2008 > steadfast supplies
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Steadfast Supplies

Can you tell me about Aesica and the company’s philosophy?

Aesica is a leading supplier of active pharmaceutical ingredients (APIs) and formulated products to the pharmaceutical industry. We are based in the UK and have three state-of-the-art manufacturing facilities. When we founded Aesica in 2004, we set out to bring something new to pharmaceutical manufacturing – an innovative, flexible and service-driven supplier of APIs, formulated products and custom synthesis solutions.

Since then we’ve more than trebled in size and built a customer base that includes the world’s largest pharmaceutical companies, leading generics manufacturers and emerging pharmaceutical companies. We also recently announced the appointment of Michael Staff as Vice President, Sales and Business Development, North America, marking the establishment of our commercial presence in North America.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Robert Hardy, CEO, led the management team which founded Aesica through the MBO of BASF’s UK API business at Cramlington in August 2004. He has more than 20 years’ experience in the pharmaceutical industry. In 1983, he joined the BASF UK pharmaceutical manufacturing business when it was part of the Boots Company PLC. Robert has a BSc (Hons) and PhD from the University of Nottingham
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating

• Designed to simplify the formulation and coating process for tablets • Optimized particle size leads to fast dissolving and increases coating process efficiency Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications. Parteck® COAT is a particle engineered polyvinyl alcohol (PVA) with a unique particle structure that enables rapid dissolution even at low temperatures leading to an increased process efficiency.
More info >>

White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement